PharmaRoth Labs (ROTH) Stock Statistics & Valuation Metrics
Total Valuation
PharmaRoth Labs has a market cap or net worth of $351.00. The enterprise value is $1.39T.
- Market Cap
- $351.00
- Enterprise Value
- $1.39T
Share Statistics
PharmaRoth Labs has 351,182,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 351,182,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PharmaRoth Labs’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 29.61%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- -0.30
- Return on Invested Capital (ROIC)
- 29.61%
- Return on Capital Employed (ROCE)
- 0.16
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.60
- Inventory Turnover
- 0.72
Income Statement
In the last 12 months, PharmaRoth Labs had revenue of 181.56K and earned -91.52K in profits. Earnings per share was -0.00.
- Revenue
- 181.56K
- Gross Profit
- 72.63K
- Operating Income
- -91.58K
- Pretax Income
- -91.58K
- Net Income
- -91.52K
- EBITDA
- -91.58K
- Earnings Per Share (EPS)
- -0.00
Stock Price Statistics
- Beta
- -0.64
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 29.00K
Financial Position
PharmaRoth Labs as a current ratio of 0.35, with Debt / Equity ratio of -45.50%
- Current Ratio
- 0.35
- Quick Ratio
- 0.18
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- -2.72
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, PharmaRoth Labs has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Analyst Forecast
The average price target for PharmaRoth Labs is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
